ENVOY MEDICAL INC (COCH)
US29415V1098 - Common Stock
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events
FDA approval to begin pivotal trial of fully implanted cochlear implant and AMA approval of CPT codes for the Company’s already FDA-approved fully...
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
Study in Otology & Neurotology outlines early experiences and potential benefits of breakthrough fully implanted cochlear implant WHITE BEAR LAKE,...
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
WHITE BEAR LAKE, Minnesota, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused...
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
The Acclaim® Fully Implanted Cochlear Implant is differentiated from existing cochlear implants and may offer new option for hearing loss patients WHITE...
Envoy Medical to Present at the LD Micro Main Event XVII
Envoy Medical to Present at the LD Micro Main Event XVII
WHITE BEAR LAKE, Minnesota, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused...
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
Performance of COCH after de-SPAC sixty day “washout” period among leaders in peer group and Envoy Medical bullish on its long-term strategy WHITE...
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy...
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss ...
Envoy Medical Secures Lending Facility of $10M
Envoy Medical Secures Lending Facility of $10M
Glen Taylor, Committed Investor and Believer in Envoy Medical’s Mission to Help People with Significant Hearing Loss, Provides Significant Additional...
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024
COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Envoy Medical (NASDAQ:COCH) just reported results for the second quarter of 202...
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
Company continues to make significant progress towards disrupting the existing cochlear implant industry with its investigational, breakthrough fully...
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
Envoy Medical’s FDA-Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit WHITE BEAR...
Envoy Medical Announces Inclusion in the Russell Microcap Index
Envoy Medical Announces Inclusion in the Russell Microcap Index
WHITE BEAR LAKE, MN, July 01, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company...
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
WHITE BEAR LAKE, Minn., June 11, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH) today announced the appointment of...
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
WHITE BEAR LAKE, MN, June 06, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company...
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
Envoy Medical in Position to Leverage its Sensor Technology WHITE BEAR LAKE, MN, June 05, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy...
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024
COCH stock results show that Envoy Medical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Envoy Medical (NASDAQ:COCH) just reported results for the first quarter of 2024...
Envoy Medical Reports First Quarter 2024 Results
The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear...